Compass Therapeutics to Present Poster at 39th Society for Immunotherapy of Cancer Annual Meeting

BOSTON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company specializing in oncology, has announced the acceptance of an abstract for a poster presentation at the upcoming 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting. The meeting will take place from November 8–10, 2024, at the George R. Brown Convention Center in Houston, TX.

The poster presentation, titled "Pharmacodynamic and Response Biomarkers in the Monotherapy Arm of a Phase 1 Trial of CTX-471, a Novel Anti-CD137 Agonist Antibody," will be presented by a team of researchers including Kris Sachsenmeier, Niharika Mettu, Martin Gutierrez, Jeffery Edenfield, Seth Rosen, Minal Barve, Karin Herrera, Natalie Warholic, Diana Albu, Alberto Visintin, Thomas Schuetz, and Tanner Johanns. The presentation will be available on Friday, November 8, 2024, from 9:00 AM to 7:00 PM CDT in Exhibit Halls AB.

Compass Therapeutics focuses on developing proprietary antibody-based therapeutics aimed at treating various human diseases, particularly in oncology. The company’s research centers on the interactions between angiogenesis, the immune system, and tumor growth. Compass's pipeline consists of innovative product candidates designed to target multiple critical biological pathways essential for an effective anti-tumor response. These pathways include the modulation of microvasculature through angiogenesis-targeted agents, the activation of immune responses via effectors in the tumor microenvironment, and the mitigation of immunosuppressive mechanisms employed by tumors to evade immune detection.

Compass Therapeutics plans to progress its product candidates through clinical development both as monotherapies and in combination with other proprietary antibodies based on robust clinical and nonclinical data. Established in 2014, the company is headquartered in Boston, Massachusetts.

The presentation materials from the SITC Annual Meeting will be accessible on the Compass Therapeutics website under the "News & Events" section once the presentation has concluded.